Minimal residual disease status predicts outcomes in patients with follicular lymphoma treated with chemoimmunotherapy on the SWOG S0016 trial.

ABSTRACT:

SUBMITTER: Danilov AV 

PROVIDER: S-EPMC12666269 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature